Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in… GlobalData Dec 11, 2024 Dr. Reddy's Laboratories, in collaboration with Shanghai Junshi Biosciences has recently launched checkpoint inhibitor Zytorvi…
Dr. Reddy’s launches Toripalimab under the brand name Zytorvi in India EP News Bureau Nov 28, 2024 Toripalimab is an immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
